$2.780
+0.192 (+6.92%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
bioAffinity Technologies Inc (BIAF) Moving Averages Convergence Divergence (MACD) indicator is -0.84, suggesting BIAF is Strong sell.
bioAffinity Technologies Inc (BIAF) 20-Day simple moving average is 3.24, while bioAffinity Technologies Inc (BIAF) share price is $—, making it Sell.
bioAffinity Technologies Inc (BIAF) 60-Day simple moving average is 5.89, while bioAffinity Technologies Inc (BIAF) share price is $—, making it Sell.
Technical Analysis for BIAF
AI Technical BIAFAs of 2026-11-07, the technical board for bioAffinity Technologies Inc (BIAF) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $2.78 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 35.795, MACD stands at -0.843 (Sell), Stochastic %K stands at 15.19 (Buy), Stochastic %D stands at 20.982 and CCI stands at -97.814.
BIAF trades below the 60-day SMA (5.89) and below the 200-day SMA (18.82). Immediate resistance sits at Classic R1 3.30, then R2 3.67. Support sits at Classic S1 2.55, then S2 2.17.
bioAffinity Technologies Inc (BIAF) Support & Resistance Level
bioAffinity Technologies Inc (BIAF) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 35.795 |
| STOCHk_14_3_3 | 15.190 |
| STOCHd_14_3_3 | 20.982 |
| CCI_20 | -97.814 |
| AO_5_34 | -1.869 |
| MOM_10 | -0.020 |
| MACD_12_26_9 | -0.843 |
bioAffinity Technologies Inc (BIAF) Relative Strength Index (RSI_14) is 35.795, creating a Neutral signal.
bioAffinity Technologies Inc (BIAF) Stochastic %K is 15.190, creating a Buy signal.
bioAffinity Technologies Inc (BIAF) Stochastic %D is 20.982, creating a Neutral signal.
bioAffinity Technologies Inc (BIAF) CCI_20 is -97.814, creating a Neutral signal.
bioAffinity Technologies Inc (BIAF) Awesome Oscillator (AO) is -1.869, creating a Sell signal.
bioAffinity Technologies Inc (BIAF) Momentum (MOM) is -0.020, creating a Sell signal.
bioAffinity Technologies Inc (BIAF) Moving Average Convergence Divergence (MACD) is -0.843, creating a Sell signal.
bioAffinity Technologies Inc (BIAF) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 2.898 | Sell |
| MA_10 | 2.936 | Sell |
| MA_20 | 3.242 | Sell |
| MA_60 | 5.889 | Sell |
| MA_200 | 18.815 | Sell |
| MA_250 | 19.402 | Sell |
bioAffinity Technologies Inc (BIAF) 5-Day simple moving average is 2.898, while bioAffinity Technologies Inc (BIAF) share price is $, making it a Sell.
bioAffinity Technologies Inc (BIAF) 10-Day simple moving average is 2.936, while bioAffinity Technologies Inc (BIAF) share price is $, making it a Sell.
bioAffinity Technologies Inc (BIAF) 20-Day simple moving average is 3.242, while bioAffinity Technologies Inc (BIAF) share price is $, making it a Sell.
bioAffinity Technologies Inc (BIAF) 60-Day simple moving average is 5.889, while bioAffinity Technologies Inc (BIAF) share price is $, making it a Sell.
bioAffinity Technologies Inc (BIAF) 200-Day simple moving average is 18.815, while bioAffinity Technologies Inc (BIAF) share price is $, making it a Sell.
bioAffinity Technologies Inc (BIAF) 250-Day simple moving average is 19.402, while bioAffinity Technologies Inc (BIAF) share price is $, making it a Sell.
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.